# TO AWARD THE BASE PERIOD FOR NIMH PSYCHOACTIVE DRUG SCREENING PROGRAM (PDSP). BASE POP: 08/30/2023-08/29/2024.

> **NIH NIH N01** · UNIV OF NORTH CAROLINA CHAPEL HILL · 2024 · $3,140,878

## Abstract

The purpose of the NIMH PDSP is to provide screening of novel synthetic compounds and natural products for
potential use as research tools or probes for basic and clinical research, as therapeutic agents for mental disorders, and as positron emission tomography (PET), single photon emission computed tomography (SPECT), and functional magnetic resonance imaging (fMRI) ligands for functional brain imaging.

## Key facts

- **NIH application ID:** 11180021
- **Project number:** 75N95023C00021-P00001-9999-1
- **Recipient organization:** UNIV OF NORTH CAROLINA CHAPEL HILL
- **Principal Investigator:** BRYAN ROTH
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $3,140,878
- **Award type:** —
- **Project period:** 2023-08-30 → 2025-08-29

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/11180021

## Citation

> US National Institutes of Health, RePORTER application 11180021, TO AWARD THE BASE PERIOD FOR NIMH PSYCHOACTIVE DRUG SCREENING PROGRAM (PDSP). BASE POP: 08/30/2023-08/29/2024. (75N95023C00021-P00001-9999-1). Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/grant/nih/11180021. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*